Cargando…

Physiologic isolation and expansion of human mesenchymal stem/stromal cells for manufacturing of cell‐based therapy products

The utilization of mesenchymal stem/stromal cells raises new hopes in treatment of diseases and pathological conditions, while at the same time bringing immense challenges for researchers, manufacturers and physicians. It is essential to consider all steps along the in vitro fabrication of cell‐base...

Descripción completa

Detalles Bibliográficos
Autores principales: Egger, Dominik, Lavrentieva, Antonina, Kugelmeier, Patrick, Kasper, Cornelia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961040/
https://www.ncbi.nlm.nih.gov/pubmed/35382547
http://dx.doi.org/10.1002/elsc.202100097
_version_ 1784677512583839744
author Egger, Dominik
Lavrentieva, Antonina
Kugelmeier, Patrick
Kasper, Cornelia
author_facet Egger, Dominik
Lavrentieva, Antonina
Kugelmeier, Patrick
Kasper, Cornelia
author_sort Egger, Dominik
collection PubMed
description The utilization of mesenchymal stem/stromal cells raises new hopes in treatment of diseases and pathological conditions, while at the same time bringing immense challenges for researchers, manufacturers and physicians. It is essential to consider all steps along the in vitro fabrication of cell‐based products in order to reach efficient and reproducible treatment outcomes. Here, the optimal protocols for isolation, cultivation and differentiation of mesenchymal stem cells are required. In this review we discuss these aspects and their influence on the final cell‐based product quality. We demonstrate that physiological in vitro cell cultivation conditions play a crucial role in therapeutic functionalities of cultivated cells. We show that three‐dimensional cell culture, dynamic culture conditions and physiologically relevant in vitro oxygen concentrations during isolation and expansion make a decisive contribution towards the improvement of cell‐based products in regenerative medicine.
format Online
Article
Text
id pubmed-8961040
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-89610402022-04-04 Physiologic isolation and expansion of human mesenchymal stem/stromal cells for manufacturing of cell‐based therapy products Egger, Dominik Lavrentieva, Antonina Kugelmeier, Patrick Kasper, Cornelia Eng Life Sci Reviews The utilization of mesenchymal stem/stromal cells raises new hopes in treatment of diseases and pathological conditions, while at the same time bringing immense challenges for researchers, manufacturers and physicians. It is essential to consider all steps along the in vitro fabrication of cell‐based products in order to reach efficient and reproducible treatment outcomes. Here, the optimal protocols for isolation, cultivation and differentiation of mesenchymal stem cells are required. In this review we discuss these aspects and their influence on the final cell‐based product quality. We demonstrate that physiological in vitro cell cultivation conditions play a crucial role in therapeutic functionalities of cultivated cells. We show that three‐dimensional cell culture, dynamic culture conditions and physiologically relevant in vitro oxygen concentrations during isolation and expansion make a decisive contribution towards the improvement of cell‐based products in regenerative medicine. John Wiley and Sons Inc. 2021-10-27 /pmc/articles/PMC8961040/ /pubmed/35382547 http://dx.doi.org/10.1002/elsc.202100097 Text en © 2021 The Authors. Engineering in Life Sciences published by Wiley‐VCH GmbH https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Reviews
Egger, Dominik
Lavrentieva, Antonina
Kugelmeier, Patrick
Kasper, Cornelia
Physiologic isolation and expansion of human mesenchymal stem/stromal cells for manufacturing of cell‐based therapy products
title Physiologic isolation and expansion of human mesenchymal stem/stromal cells for manufacturing of cell‐based therapy products
title_full Physiologic isolation and expansion of human mesenchymal stem/stromal cells for manufacturing of cell‐based therapy products
title_fullStr Physiologic isolation and expansion of human mesenchymal stem/stromal cells for manufacturing of cell‐based therapy products
title_full_unstemmed Physiologic isolation and expansion of human mesenchymal stem/stromal cells for manufacturing of cell‐based therapy products
title_short Physiologic isolation and expansion of human mesenchymal stem/stromal cells for manufacturing of cell‐based therapy products
title_sort physiologic isolation and expansion of human mesenchymal stem/stromal cells for manufacturing of cell‐based therapy products
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961040/
https://www.ncbi.nlm.nih.gov/pubmed/35382547
http://dx.doi.org/10.1002/elsc.202100097
work_keys_str_mv AT eggerdominik physiologicisolationandexpansionofhumanmesenchymalstemstromalcellsformanufacturingofcellbasedtherapyproducts
AT lavrentievaantonina physiologicisolationandexpansionofhumanmesenchymalstemstromalcellsformanufacturingofcellbasedtherapyproducts
AT kugelmeierpatrick physiologicisolationandexpansionofhumanmesenchymalstemstromalcellsformanufacturingofcellbasedtherapyproducts
AT kaspercornelia physiologicisolationandexpansionofhumanmesenchymalstemstromalcellsformanufacturingofcellbasedtherapyproducts